Statement of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Cash flows from operating activities:
Net income attributable to common shareholders	$ 6,976,016	$ 3,252,328
Accretion of investments	(2,161,508)	(4,861,780)
Realized investment gains, net	(17,058,173)	(889,253)
Unrealized trading gains included in income	722,573	36,876
Realized trading (gains) losses included in income	143,957	288,631
Amortization of deferred policy acquisition costs	369,786	56,432
Amortization of cost of insurance acquired	985,650	1,064,353
Depreciation	1,303,829	1,260,697
Net income attributable to noncontrolling interest	3,067,726	617,684
Charges for mortality and administration of universal life and annuity products	(6,651,876)	(6,885,257)
Interest credited to account balances	4,985,077	5,118,692
Change in accrued investment income (loss)	(229,926)	11,851
Change in reinsurance receivables	998,863	1,116,386
Change in policy liabilities and accruals	(5,123,893)	(6,146,134)
Change in income taxes payable	3,229,286	(3,318,794)
Change in other assets and liabilities, net	(5,197,626)	(1,666,512)
Net cash provided by (used in) operating activities	(13,640,239)	(10,943,800)
Cash flows from investing activities:
Fixed maturities available for sale	44,228,405	37,802,120
Equity securities available for sale	14,686,816	681,209
Trading securities	1,992,704	24,017,415
Mortgage loans	2,121,284	15,428,176
Discounted mortgage loans	6,919,641	17,424,049
Real estate	53,674,168	8,880,306
Policy loans	3,322,613	3,617,041
Short term investment	960,148	0
Total proceeds from investments sold and matured	127,905,779	107,850,316
Cost of investments acquired:
Fixed maturities available for sale	(60,986,549)	(34,443,048)
Equity securities available for sale	(12,963,380)	(10,428,300)
Trading securities	(371,388)	(24,105,644)
Mortgage loans	(1,727,680)	(4,539,234)
Discounted mortgage loans	(621,210)	(12,222,291)
Real estate	(7,424,311)	(13,014,568)
Policy loans	(2,566,138)	(2,886,428)
Short-term investments	(5,342,329)	(25,000)
Total cost of investments acquired	(92,002,985)	(101,664,513)
Disposal (purchase) of property and equipment	(1,600,000)	0
Net cash used in investing activities	34,302,794	6,185,803
Cash flows from financing activities:
Policyholder contract deposits	5,304,502	5,798,948
Policyholder contract withdrawals	(6,323,472)	(5,311,025)
Proceeds from notes payable/line of credit	1,600,000	3,000,000
Payments of principal on notes payable/line of credit	(16,297,534)	(2,760,420)
Purchase of treasury stock	(927,904)	(286,988)
Non-controlling distributions of consolidated subsidiary	(6,833,748)	834,854
Cash received in reinsurance recapture	(3,045,574)	0
Net cash provided by (used in) financing activities	(26,523,730)	1,275,369
Net increase (decrease) in cash and cash equivalents	(5,861,175)	(3,482,628)
Cash and cash equivalents at beginning of period	19,838,618	23,321,246
Cash and cash equivalents at end of period	$ 13,977,443	$ 19,838,618